2,459
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Urban-rural differences in the impacts of multiple chronic disease on functional limitations and work productivity among Chinese adults

ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Article: 1975921 | Received 16 May 2021, Accepted 28 Aug 2021, Published online: 17 Sep 2021

References

  • Yang GP, Kong LMD, Zhao WMD, et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372:1697–12.
  • Wang L, Kong L, Wu F, et al. Preventing chronic diseases in China. Lancet. 2005;366:1821–1824.
  • Zhao Y, Zhang L, Zhao S, et al. Impact of multimorbidity on health service use and catastrophic health expenditure in China: an analysis of data from a nationwide longitudinal survey. The Lancet (British edition). 2019;394:S69–S69.
  • Zhao Y, Atun R, Oldenburg B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020;8:e840–e849.
  • Wang L, Si L, Cocker F, et al. A systematic review of cost-of-illness studies of multimorbidity. Appl Health Econ Health Policy. 2018;16:15–29.
  • Sum G, Hone T, Atun R, et al. Multimorbidity and out-of-pocket expenditure on medicines: a systematic review. Eur J Public Health. 2017;27. DOI:https://doi.org/10.1093/eurpub/ckx187.233.
  • Marthias T, Anindya K, Ng N, et al. Impact of non-communicable disease multimorbidity on health service use, catastrophic health expenditure and productivity loss in Indonesia: a population-based panel data analysis study. BMJ Open. 2021;11:e041870–e041870.
  • Anindya K, Ng N, Atun R, et al. Effect of multimorbidity on utilisation and out-of-pocket expenditure in Indonesia: quantile regression analysis. BMC Health Serv Res. 2021;21:427.
  • Zhao Y, Zhang P, Lee JT, et al. The prevalence of metabolic disease multimorbidity and its associations with spending and health outcomes in middle-aged and elderly chinese adults. Front Public Health. 2021;9:658706.
  • Zhao Y, Atun R, Anindya K, et al. Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis. BMJ Glob Health. 2021;6:e004042.
  • Chen H, Chen Y, Cui B. The association of multimorbidity with healthcare expenditure among the elderly patients in Beijing, China. Arch Gerontol Geriatr. 2018;79:32–38.
  • Zhao Y, Zhang P, Oldenburg B, et al. The impact of mental and physical multimorbidity on healthcare utilization and health spending in China: a nationwide longitudinal population‐based study. Int J Geriatr Psychiatry. 2021;36:500–510.
  • Pan T, Mercer SW, Zhao Y, et al. The association between mental-physical multimorbidity and disability, work productivity, and social participation in China: a panel data analysis. BMC Public Health. 2021;21:376.
  • Su P, Ding H, Zhang W, et al. The association of multimorbidity and disability in a community-based sample of elderly aged 80 or older in Shanghai, China. BMC Geriatr. 2016;16:178.
  • Zhao YW, Haregu TN, He L, et al. The effect of multimorbidity on functional limitations and depression amongst middle-aged and older population in China: a nationwide longitudinal study. Age Ageing. 2021;50:190–197.
  • Meraya AM, Sambamoorthi U. Chronic condition combinations and productivity loss among employed nonelderly adults (18 to 64 Years). J Occup Environ Med. 2016;58:974–978.
  • Ubalde López M, Arends I, Almansa J, et al. Beyond return to work: the effect of multimorbidity on work functioning trajectories after sick leave due to common mental disorders. J Occup Rehabil. 2017;27:210–217.
  • Ishida M, Hulse ESG, Mahar RK, et al. The joint effect of physical multimorbidity and mental health conditions among adults in Australia. Prev Chronic Dis. 2020;17:E157–E157.
  • Troelstra SA, Straker L, Harris M, et al. Multimorbidity is common among young workers and related to increased work absenteeism and presenteeism: results from the population-based Raine Study cohort. Scand J Work Environ Health. 2020;46:218–227.
  • Sum G, Ishida M, Koh GC-H, et al. Implications of multimorbidity on healthcare utilisation and work productivity by socioeconomic groups: cross-sectional analyses of Australia and Japan. PloS One. 2020;15:e0232281–e0232281.
  • Cabral GG, de Souza ACD, Barbosa IR, et al. Multimorbidity and its impact on workers: a review of longitudinal studies. Saf Health Work. 2019;10:393–399.
  • Zhang W, Sun H, Li X. The association between chronic conditions and non-agricultural work productivity loss among the middle-aged Chinese population. J Occup Environ Med. 2018;60:832–838.
  • Li Y, Chi I, Zhang K, et al. Comparison of health services use by Chinese urban and rural older adults in Yunnan province. Geriatr Gerontol Int. 2006;6:260–269.
  • Ge D, Chu J, Zhou C, et al. Rural-urban difference in the use of annual physical examination among seniors in Shandong, China: a cross-sectional study. Int J Equity Health. 2017;16:86.
  • Shi L. Health care in China: a rural-urban comparison after the socioeconomic reforms. Bull World Health Organ. 1993;71:723–736.
  • You X, Zhang Y, Zeng J, et al. Disparity of the Chinese elderly’s health-related quality of life between urban and rural areas: a mediation analysis. BMJ Open. 2019;9:e024080–e024080.
  • Chen N, Li X, Wang J, et al. Rural-urban differences in the association between disability and body mass index among the oldest-old in China. Arch Gerontol Geriatr. 2019;81:98–104.
  • Liu M, Wang JH, Yang SS, et al. Evaluation of activities of daily living and related factors in community elderly people in urban and rural areas of Beijing. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:268–272.
  • Cheng C, Yang CY, Inder K, et al. Urban–rural differences in mental health among Chinese patients with multiple chronic conditions. Int J Ment Health Nurs. 2020;29:224–234.
  • Yao -S-S, Cao G-Y, Han L, et al. Prevalence and patterns of multimorbidity in a nationally representative sample of older chinese: results from the china health and retirement longitudinal study. J Gerontol A Biol Sci Med Sci. 2020;75:1974–1980.
  • Wang S, Kou C, Liu Y, et al. Rural–Urban differences in the prevalence of chronic disease in Northeast China. Asia Pac J Public Health. 2015;27:394–406.
  • Yaohui Z, Yisong HU, Smith JP, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43:61–68.
  • Barnett KP, Mercer SWP, Norbury MM, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43.
  • Fortin M, Stewart M, Poitras M-E, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Anna Family Med. 2012;10:142–151.
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–2219.
  • Chobanian AV. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289:2560–2572.
  • American Diabetes A. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42:S13–S28.
  • Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. Jama. 2013;310:948–959.
  • Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196–203.
  • Hu D. Dyslipidemia and management of atherosclerotic cardiovascular diseases in China: new evidence and new guidelines. Cardiovasc Innovations Appl. 2017;2:143–145.
  • Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. jama. 1963;185:914–919.
  • Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186.
  • Qian J, Ren X. Association between comorbid conditions and BADL/IADL disability in hypertension patients over age 45: based on the China health and retirement longitudinal study (CHARLS). Medicine (Baltimore). 2016;95:e4536–e4536.
  • Bowling CB, Deng L, Sakhuja S, et al. Prevalence of activity limitations and association with multimorbidity among US adults 50 to 64 years old. J Gen Intern Med. 2019;34:2390–2396.
  • Jindai K, Nielson CM, Vorderstrasse BA, et al. Multimorbidity and functional limitations among adults 65 or older, NHANES 2005-2012. Prev Chronic Dis. 2016;13:E151–E151.
  • Jiao D, Watanabe K, Sawada Y, et al. Multimorbidity and functional limitation: the role of social relationships. Arch Gerontol Geriatr. 2021;92:104249.
  • Singer L, Green M, Rowe F, et al. Trends in multimorbidity, complex multimorbidity and multiple functional limitations in the ageing population of England, 2002–2015. J Comorb. 2019;9:2235042–2235042X19872030.
  • Wang HH, Wang JJ, Lawson KD, et al. Relationships of multimorbidity and income with hospital admissions in 3 health care systems. Anna Family Med. 2015;13:164–167.
  • Van Merode T, Van De Ven K, Van Den Akker M. Patients with multimorbidity and their treatment burden in different daily life domains: a qualitative study in primary care in the netherlands and Belgium. J Comorb. 2018;8:9–15.
  • Quah JHM, Wang P, Ng RRG, et al. Health‐related quality of life of older Asian patients with multimorbidity in primary care in a developed nation. Geriatr Gerontol Int. 2017;17:1429–1437.
  • Smith SM, Soubhi H, Fortin M, et al. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ. 2012;345:809–e5205.
  • Uijen AA, van de Lisdonk EH. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract. 2008;14:28–32.
  • Smith SM, Wallace E, O’Dowd T, et al. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev. 2016;2017:CD006560–CD006560.
  • Wallace E, Salisbury C, Guthrie B, et al. Managing patients with multimorbidity in primary care. BMJ. 2015;350:h176–h176.
  • Firth J, Siddiqi N, Koyanagi A, et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019;6:675–712.
  • Cavagnolli G, Pimentel AL, Freitas PAC, et al. Effect of ethnicity on HbA1c levels in individuals without diabetes: systematic review and meta-analysis. PLoS One. 2017;12:e0171315–e0171315.
  • Calderon‐Larrañaga A, Vetrano DL, Ferrucci L, et al. Multimorbidity and functional impairment–bidirectional interplay, synergistic effects and common pathways. J Intern Med. 2019;285:255–271.
  • Sturmberg JP, Bennett JM, Martin CM, et al. ‘Multimorbidity’ as the manifestation of network disturbances. J Eval Clin Pract. 2017;23:199–208.
  • World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
  • Goetzel RZ, Henke RM, Tabrizi M, et al. Do workplace health promotion (wellness) programs work? J Occup Environ Med. 2014;56:927–934.
  • Cancelliere C, Cassidy JD, Ammendolia C, et al. Are workplace health promotion programs effective at improving presenteeism in workers? A systematic review and best evidence synthesis of the literature. BMC Public Health. 2011;11:395.
  • Mills PR, Kessler RC, Cooper J, et al. Impact of a health promotion program on employee health risks and work productivity. Am J Health Promot. 2007;22:45–53.
  • Stoudemire A. Psychological factors affecting medical conditions. Washington DC: American Psychiatric Press; 1995.